Phthalic Acid

Phthalic Acid

SCHEMBL467124

O=C(O)c1ccccc1C(=O)O.[NaH].[NaH]

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.93
ALOX15 P16050 1/20 0.93
AKR1C3 P42330 3/20 0.67
NAPRT Q6XQN6 2/20 0.65
KDM4E B2RXH2 1/20 0.65
CA12 O43570 1/20 0.65
CA1 P00915 1/20 0.65
CA2 P00918 1/20 0.65
HMGB1 P09429 1/20 0.65
HPGD P15428 1/20 0.65
CA4 P22748 1/20 0.65
CA6 P23280 1/20 0.65
CA7 P43166 1/20 0.65
SMN1; SMN2 Q16637 1/20 0.65
CA9 Q16790 1/20 0.65
CA14 Q9ULX7 1/20 0.65
MAPT P10636 2/20 0.62
HDAC8 Q9BY41 1/20 0.62
POLB P06746 1/20 0.59
NR4A1 P22736 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phthalic Acid SCHEMBL105219 1.00 ALDH1A1 (0.93) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL28164268 1.00 ALDH1A1 (0.93) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL29176753 1.00 ALDH1A1 (0.93) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL16585284 1.00 ALDH1A1 (0.93) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL7030038 1.00 ALDH1A1 (0.93) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL6242354 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL20503446 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL4286257 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL6242357 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL28258531 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 499 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12529628-B2 Microbeads and preparation method therefor LG CHEM, LTD. (KR) 2026-01-20 US claimed
CN-120136074-A Preparation method of hard carbon negative electrode material of sodium ion battery 山东海化集团有限公司 2025-06-13 CN claimed
CN-120019108-A Additive for heat treated foamable polypropylene 弗纳技术股份有限公司 2025-05-16 CN claimed
CN-119674076-A Negative electrode additive and preparation method and application thereof 江苏正力新能电池技术股份有限公司 2025-03-21 CN claimed
US-12246115-B2 Medical device and method of manufacturing same TORAY INDUSTRIES, INC. (JP) 2025-03-11 US claimed
EP-4183857-B1 USE OF A LUBRICANT RELEASE AGENT COMPOSITION BARALDI S R L (IT) 2025-01-29 EP claimed
CN-118871534-A Process for producing epsilon-type copper phthalocyanine pigment composition 大日精化工业株式会社 2024-10-29 CN claimed
CN-118056892-A Novel lubricant release agent composition 巴拉尔迪有限责任公司 2024-05-21 CN claimed
CN-116516433-B Green rapid preparation method of metal organic framework compound film coating 中国科学院深圳先进技术研究院 2024-04-26 CN claimed
EP-3858391-B1 MEDICAL DEVICE AND METHOD OF MANUFACTURING SAME TORAY INDUSTRIES (JP) 2024-02-07 EP claimed
EP-1433482-B1 Aqueous preparation containing a shark-derived chondroitin iron sulfate colloid NIPRO CORP (JP) 2006-12-20 EP claimed
US-20040132689-A1 Aqueous preparation containing a shark-derived chondroitin iron sulfate colloid NIPRO CORPORATION (JP) 2004-07-08 US claimed
EP-1433482-A1 Aqueous preparation containing a shark-derived chondroitin iron sulfate colloid Nipro Corporation (JP) 2004-06-30 EP claimed
CN-1504196-A Use of glycyrrhizin and its derivatives as mcp-1 production inhibitors 日本米诺发源制药株式会社 2004-06-16 CN claimed
CN-1498623-A Glycyrrhizic acid and its derivative used as RANTES inducer 日本米诺发源制药株式会社 2004-05-26 CN claimed
EP-0970156-A1 CHEMICAL-MECHANICAL POLISHING SLURRY FORMULATION AND METHOD FOR TUNGSTEN AND TITANIUM THIN FILMS ADVANCED MICRO DEVICES, INC. (US) 2000-01-12 EP claimed
WO-1998042791-A1 CHEMICAL-MECHANICAL POLISHING SLURRY FORMULATION AND METHOD FOR TUNGSTEN AND TITANIUM THIN FILMS ADVANCED MICRO DEVICES, INC. (US) 1998-10-01 WO claimed
CN-1062912-A Stable halogen-containing polymer compositions ATOCHEM NORTH AMERICA (US) 1992-07-22 CN claimed
EP-0492803-A1 Stabilized halogen containing polymer compositions ELF ATOCHEM NORTH AMERICA, INC. (US) 1992-07-01 EP claimed
US-4507468-A Method for purifying polyphenylene sulfide DAINIPPON INK AND CHEMICALS, INC. (JP) 1985-03-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12529628-B2 Microbeads and preparation method therefor SLC6A11, SLC16A7, SLC5A11 ALDH1A1 1940/4885ALOX15 4334/4885AKR1C3 1478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.